Objective To quantify and compare levels of potential biomarkers in neonates with (i) Bronchopulmonary dysplasia (BPD); (ii) BPD-associated pulmonary hypertension (BPD-PH); (iii) PH without BPD; and (iv) neonates without lung disease at similar to 36 weeks postmenstrual age.
Study design Multiple potential biomarkers were measured in plasma samples of 90 patients using a multi-spot enzyme-linked immunosorbent assay. Statistical tests done included one-way ANOVA to compare levels of biomarkers between different groups.
Results Higher levels of ICAM-1 were present in infants with BPD and correlated with its severity. Infants with BPD have significantly higher levels of ANG-2 and lower levels of ANG-1. Infants with PH have higher levels of: IL-6, IL-8, IL-10, and TNF-alpha. Infants with BPD-PH have significantly lower levels of MCP-1 and higher levels of IL-1 beta than infants with PH without BPD.
Conclusion ICAM-1 may be used as a specific biomarker for diagnosis of BPD and its severity.
Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension
Creators
Mitali Sahni - Sunrise Medical
Bettie Yeboah - St. Christopher's Hospital for Children
Pragnya Das - Cooper University Hospital
Dilip Shah - Cooper University Hospital
Devasena Ponnalagu - The Ohio State University
Harpreet Singh - The Ohio State University
Leif D. Nelin - Nationwide Children's Hospital
Vineet Bhandari - Cooper University Hospital
Publication Details
Journal of perinatology, v 40(11), pp 1634-1643
Publisher
Springer Nature
Number of pages
10
Grant note
R01-HL133050 / National Institute of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
16GRNT29430000 / American Heart Association
Resource Type
Journal article
Language
English
Academic Unit
Pediatrics
Web of Science ID
WOS:000561267400001
Scopus ID
2-s2.0-85089526842
Other Identifier
991019167537204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: